No painkillers or paracetamol recommended after Covaxin jab: Bharat Biotech

Bharat Biotech on Wednesday said no painkillers or paracetamol are recommended after being vaccinated with its COVID-19 vaccine Covaxin.Stating that it has received feedback that certain immunisation centres are recommending taking three paracetamol 500mg tablets along with Covaxin for children, the company clarified that such a step was not required.No paracetamol or painkillers are recommended after being vaccinated with Covaxin, Bharat Biotech said in a tweet.Paracetamol was recommended along with certain other COVID-19 vaccines and is not recommended for Covaxin, it asserted.Through our clinical trials spanning 30,000 individuals, approximately 10-20 per cent individuals report side effects.

Bharat Biotech on Wednesday said no painkillers or paracetamol are recommended after being vaccinated with its COVID-19 vaccine Covaxin.

Stating that it has received feedback that certain immunisation centres are recommending taking three paracetamol 500mg tablets along with Covaxin for children, the company clarified that such a step was not required.

''No paracetamol or painkillers are recommended after being vaccinated with Covaxin,'' Bharat Biotech said in a tweet.

Paracetamol was recommended along with certain other COVID-19 vaccines and is not recommended for Covaxin, it asserted.

''Through our clinical trials spanning 30,000 individuals, approximately 10-20 per cent individuals report side effects. Most of these are mild, resolve within 1-2 days, and do not require medication. Medication is only recommended only after you consult a physician,'' the company said.

Last month, the Drugs Controller General of India (DCGI) had granted emergency use authorisation to indigenously-developed Bharat Biotech's Covaxin for children above 12 years with certain conditions.

Prime Minister Narendra Modi had announced that vaccination against COVID-19 for children between 15-18 years would start from January 3.

Subsequently, India opened up vaccination for the 15-18 years age-group on Monday and so far over 85 lakh beneficiaries in the category have received the first shot.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)